Device Trial Radar · NCT04472091
Genicular Artery Embolization (GAE) for Osteoarthritic Knee Pain
Last checked: Nov 19, 2026Latest source record: Feb 24, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Withdrawn
Enrollment
0
Actual
Start
Jan 15, 2025
Primary completion
Nov 1, 2026
Study completion Nov 1, 2026
Sponsor
- Lead sponsor
- Andrew PicelAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jul 15, 2020
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 40 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this investigation is to evaluate the safety of the geniculate artery embolization (GAE) procedure with HydroPearl® Microspheres in 30 patients with knee pain caused by osteoarthritis with 24 months follow-up. The GAE procedure is an arterial embolization procedure that blocks abnormal blood vessels caused be knee arthritis in order to evaluate the effect on knee pain.
Conditions
- Knee Osteoarthritis
- Knee Pain Chronic
- Knee Pain Swelling
- Knee Arthritis
- Arterial Occlusion
Interventions
Genicular artery embolization (GAE)Device
Participants will undergo GAE with HydroPearl® Microspheres (polyethylene glycol microspheres, Terumo Medical, Somerset NJ).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of patients with treatment related adverse eventsTime frame: 1 month post GAE
- Number of patients with treatment related adverse eventsTime frame: 6 months post GAE
- Number of patients with treatment related adverse eventsTime frame: 12 months post GAE
1 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Stanford University
Palo Alto, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.